-transparent.png){kind=logo}
Information on the origin of brain glutathione and the possibility of its transport from blood to brain is limited. We found a substantial uptake of 35S-labeled glutathione by the rat brain using the carotid artery injection technique. The brain uptake index of glutathione with and without an irreversible gamma-glutamyl transpeptidase inhibitor, acivicin, was similar. No significant differences in the regional uptake of labeled glutathione were found in rats pretreated with acivicin. The brain uptake index of tracer glutathione was similar to that of cysteine tracer and was lower than that of phenylalanine. The transport of oxidized glutathione (glutathione disfulfide) across the blood-brain barrier was not significantly different from that of sucrose, an impermeable marker. Brain radioactivity 15 s after carotid artery injection of labeled glutathione to rats pretreated with acivicin was predominantly in the form of glutathione. The in vivo glutathione uptake was saturable with an apparent Km of 5.84 mM. Amino acids, amino acid analogues, and other compounds [cysteine, phenylalanine, glutathione disulfide, gamma-glutamylglutamate, gamma-glutamyl p-nitroanilide, 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid (BCH)] did not affect glutathione transport. Our data suggest that glutathione is transported across the blood-brain barrier by a saturable and specific mechanism.
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
March 1984,
Journal of neurochemistry,
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
October 2004,
The Journal of pharmacology and experimental therapeutics,
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
April 1999,
Advanced drug delivery reviews,
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
January 1987,
Journal of neuroscience research,
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
March 1995,
Biochemical pharmacology,
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
January 2005,
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics,
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
January 2015,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
October 1986,
The American journal of physiology,
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
November 2009,
Immunotherapy,
R Kannan, and
J F Kuhlenkamp, and
E Jeandidier, and
H Trinh, and
M Ookhtens, and
N Kaplowitz
August 1994,
Neurosurgery,
